share_log

小鵬汽車-W:翌日披露報表

XPENG-W: Next Day Disclosure Return

香港交易所 ·  Mar 25 10:17
Summary by Moomoo AI
小鵬汽車有限公司於2024年3月25日根據2019年股權激勵計劃,發行了2,070,152股A類普通股,以滿足限制性股份單位的要求。此次發行後,公司的已發行股本從1,538,143,883股增加至1,540,214,035股,增幅為0.11%。該次發行的股份價格為每股HKD 0,相較於上一個營業日的收市價HKD 34.55,折讓幅度為100%。公司確認,所有相關的法律及上市規定均已遵守,並且發行人董事會已正式授權批准了此次股份發行。
小鵬汽車有限公司於2024年3月25日根據2019年股權激勵計劃,發行了2,070,152股A類普通股,以滿足限制性股份單位的要求。此次發行後,公司的已發行股本從1,538,143,883股增加至1,540,214,035股,增幅為0.11%。該次發行的股份價格為每股HKD 0,相較於上一個營業日的收市價HKD 34.55,折讓幅度為100%。公司確認,所有相關的法律及上市規定均已遵守,並且發行人董事會已正式授權批准了此次股份發行。
XIAO PENG AUTOMOBILE CO., LTD. ISSUED 2,070,152 SHARES OF CLASS A ORDINARY SHARES ON MARCH 25, 2024 UNDER THE EQUITY INCENTIVE PLAN 2019 TO MEET THE REQUIREMENTS OF RESTRICTED SHARE UNITS. Following the issuance, the Company's issued share capital increased from 1,538,143,883 shares to 1,540,214,035 shares, an increase of 0.11%. The share issue is priced at HKD 0 per share, representing a discount of 100% compared to the closing price of HKD 34.55 on the previous business day. The Company confirms that all relevant laws and listing requirements have been complied with and that the issuer's Board of Directors has formally authorized the issuance of shares.
XIAO PENG AUTOMOBILE CO., LTD. ISSUED 2,070,152 SHARES OF CLASS A ORDINARY SHARES ON MARCH 25, 2024 UNDER THE EQUITY INCENTIVE PLAN 2019 TO MEET THE REQUIREMENTS OF RESTRICTED SHARE UNITS. Following the issuance, the Company's issued share capital increased from 1,538,143,883 shares to 1,540,214,035 shares, an increase of 0.11%. The share issue is priced at HKD 0 per share, representing a discount of 100% compared to the closing price of HKD 34.55 on the previous business day. The Company confirms that all relevant laws and listing requirements have been complied with and that the issuer's Board of Directors has formally authorized the issuance of shares.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more